Here is your trade on Clovis Oncology (CLVS) (December 29, 2015)


<!--VIDEOPOSTER --> CLVS  Clovis Oncology ( NASDAQ:CLVS ): we had a lot of people in the forum talking about this this stock. You can see what happened; and no, the stock didn’t split 2-for-1 or 3-for-1 or whatever, it just got crushed. But since it fell the stock has been squeezing tighter and tighter right about 35.00ish, 34.75, something like that. It’s been squeezing in a tight range. We’re finally seeing it start to break out where I wanted to give you the “heads up”. Unless Read more [...]

6 Common Investment Mistakes We All Make


Some lessons are learned the hard way. Unfortunately, some of those painful lessons are learned from investment mistakes that cost money. The good news is that new investors can learn from the mistakes of their forbears so that they don’t repeat them. Here are 6 common investment mistakes we all make. 1. Focusing on Short Term Losses and Gains Most asset classes aren’t intended to make you a quick buck. Sure, you can get wind of some good news that a company is about to announce and buy its stock Read more [...]

Is Alibaba Group All Set for the Time to Come?


In the last two years, Alibaba Group Holding Ltd. (NYSE:BABA) has been in the investors’ and analysts’ limelight, due to its stock price movements. Another factor is its plans to expand its empire into various industries. As we enter the New Year, Bidness Etc discusses a forward-looking strategy of the Chinese juggernaut. Going Forward For quite some, Alibaba has struggled to win its investors’ support. However, it has found itself in hot water until now. It has ventured into several projects Read more [...]

2015 Goodbye! 2016 Hello?


As 2015 comes to a close, we reflect on the turmoil that we witnessed throughout the year. It has been intensifying. Volatility is rising. With the exception of Japan and, less so, some in Europe, developed markets are flat or down this year-to-date. We will use year-to-date total return (closing prices plus yield) through December 22.  SPY, the US equity ETF for the S&P 500 cap-weighted index, had a total return of 0.75%.  The equal weighted ETF for the same 500 stocks is RSP.  Its total Read more [...]

Improving Bogles 50/50 Portfolio


Jack Bogle has made changes inside his personal investment portfolio. In a news interview last week, the legendary indexer revealed that his 60% allocation to U.S. stocks and 40% to bonds via index funds (Nasdaq:VBINX) has shifted to a more conservative asset split of 50/50 in each group. Bogle is the 86-year old founder of Vanguard Group, the world’s largest mutual fund company. For most investors, Bogle’s personal asset mix is irrelevant to how their own investment portfolio should be built. Read more [...]

Republicans Are Revolutionaries, Not Conservatives: A Response to ThomasSchaller


Rep. Paul Ryan (R-WI) waves as he comes off the stage with his family during a 2012 presidential campaign event in Reno, Nevada. (AP Photo/Mary Altaffer) There is much to commend in Thomas Schaller’s recent piece describing the built-in structural advantages that the Republican Party enjoys in the American electoral system. Some analysts believe this advantage derives from the systematic gerrymandering of legislative districts; others declare it a result of a voluntary demographic “sorting” Read more [...]

A screener of screeners, Wootrader is creating affordable predictive analytics models for all kinds of investors


Atanas Stoyanov is the CEO of Wootrader. What is Wootrader? Atanas Stoyanov, CEO of Wootrader Wootrader is the only complete system that uses technical analysis, company fundamentals, analysts estimates, options volatility, guru strategies, stock sentiment and more to generate a ranking for each stock. What makes Wootrader so radically different is that it adapts to the dynamically changing stock markets by using weighted predictive analytics models that have been used for years in other industries, Read more [...]